Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase

Burcu Aslan; Stefan Edward Hubner; Judith A. Fox; Pietro Taverna; William G. Wierda; Steven M. Kornblau; Varsha Gandhi

doi:10.3324/haematol.2021.279158

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase

Burcu Aslan, Stefan Edward Hubner, Judith A. Fox, Pietro Taverna, William G. Wierda, Steven M. Kornblau, Varsha Gandhi

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	292-297
Number of pages	6
Journal	Haematologica
Volume	107
Issue number	1
DOIs	https://doi.org/10.3324/haematol.2021.279158
State	Published - Jan 2022

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2021.279158

Cite this

@article{de181d1fe4b544329aae801f8676eb53,

title = "Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase",

author = "Burcu Aslan and Hubner, {Stefan Edward} and Fox, {Judith A.} and Pietro Taverna and Wierda, {William G.} and Kornblau, {Steven M.} and Varsha Gandhi",

note = "Funding Information: Funding: this work was supported in part by The University of Texas MD Anderson Cancer Center Moon Shot Program, a Sponsored Research Agreement from Sunesis Pharmaceuticals, and by the NIH/NCI through award number P30CA016672.",

year = "2022",

month = jan,

doi = "10.3324/haematol.2021.279158",

language = "English (US)",

volume = "107",

pages = "292--297",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "1",

}

TY - JOUR

T1 - Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase

AU - Aslan, Burcu

AU - Hubner, Stefan Edward

AU - Fox, Judith A.

AU - Taverna, Pietro

AU - Wierda, William G.

AU - Kornblau, Steven M.

AU - Gandhi, Varsha

N1 - Funding Information: Funding: this work was supported in part by The University of Texas MD Anderson Cancer Center Moon Shot Program, a Sponsored Research Agreement from Sunesis Pharmaceuticals, and by the NIH/NCI through award number P30CA016672.

PY - 2022/1

Y1 - 2022/1

UR - http://www.scopus.com/inward/record.url?scp=85122307846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122307846&partnerID=8YFLogxK

U2 - 10.3324/haematol.2021.279158

DO - 10.3324/haematol.2021.279158

M3 - Letter

C2 - 34498444

AN - SCOPUS:85122307846

SN - 0390-6078

VL - 107

SP - 292

EP - 297

JO - Haematologica

JF - Haematologica

IS - 1

ER -

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this